Integrated Diagnostics (UK) Buy Hold or Sell Recommendation
| IDHC Stock | 0.40 0.02 5.26% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Integrated Diagnostics Holdings is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Integrated Diagnostics Holdings given historical horizon and risk tolerance towards Integrated Diagnostics. When Macroaxis issues a 'buy' or 'sell' recommendation for Integrated Diagnostics Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Integrated Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Integrated and provide practical buy, sell, or hold advice based on investors' constraints. Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Integrated |
Execute Integrated Diagnostics Buy or Sell Advice
The Integrated recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Integrated Diagnostics Holdings. Macroaxis does not own or have any residual interests in Integrated Diagnostics Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Integrated Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Integrated Diagnostics Trading Alerts and Improvement Suggestions
| Integrated Diagnostics has some characteristics of a very speculative penny stock | |
| Integrated Diagnostics had very high historical volatility over the last 90 days | |
| Integrated Diagnostics is unlikely to experience financial distress in the next 2 years | |
| About 34.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Integrated Diagnostics Holdings PLC Q3 2024 Earnings Call Highlights Strong Revenue ... By GuruFocus - Investing.com Canada |
Integrated Diagnostics Returns Distribution Density
The distribution of Integrated Diagnostics' historical returns is an attempt to chart the uncertainty of Integrated Diagnostics' future price movements. The chart of the probability distribution of Integrated Diagnostics daily returns describes the distribution of returns around its average expected value. We use Integrated Diagnostics Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Integrated Diagnostics returns is essential to provide solid investment advice for Integrated Diagnostics.
| Mean Return | -0.07 | Value At Risk | -5.13 | Potential Upside | 5.88 | Standard Deviation | 3.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Integrated Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Integrated Diagnostics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 4.9M | (17.1M) | (127.6M) | (30.2M) | (104.9M) | (99.7M) | |
| Change In Cash | (3.7M) | 191.2M | 291.3M | (242.9M) | 25.7M | 24.5M | |
| Free Cash Flow | 479.4M | 756.5M | 2.0B | (100.1M) | 217.7M | 206.8M | |
| Depreciation | 153.5M | 185.4M | 238.6M | 317.3M | 401.2M | 421.3M | |
| Other Non Cash Items | 17.6M | 18.4M | 4.9M | (704.4M) | 87.7M | 92.1M | |
| Capital Expenditures | 218.0M | 126.0M | 263.7M | 308.8M | 325.9M | 179.8M | |
| Net Income | 758.1M | 969.1M | 2.2B | 853.6M | 737.4M | 723.7M | |
| End Period Cash Flow | 408.9M | 600.1M | 891.5M | 648.5M | 674.3M | 596.0M | |
| Investments | 18.3M | (55.0M) | (1.3B) | 990.1M | (243.9M) | (231.7M) | |
| Net Borrowings | 46.2M | (84.6M) | (56.4M) | (54.6M) | (49.1M) | (46.7M) | |
| Dividends Paid | 450.5M | 450.7M | 478.7M | 1.4B | 1.6B | 1.7B | |
| Change To Netincome | 51.4M | 91.6M | 208.9M | 500.2M | 575.2M | 604.0M |
Integrated Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Integrated Diagnostics or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Integrated Diagnostics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Integrated stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 3.58 | |
Ir | Information ratio | -0.05 |
Integrated Diagnostics Volatility Alert
Integrated Diagnostics Holdings exhibits very low volatility with skewness of -0.02 and kurtosis of 2.41. Integrated Diagnostics Holdings is a potential penny stock. Although Integrated Diagnostics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Integrated Diagnostics Holdings. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Integrated instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Integrated Diagnostics Fundamentals Vs Peers
Comparing Integrated Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Integrated Diagnostics' direct or indirect competition across all of the common fundamentals between Integrated Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Integrated Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Integrated Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Integrated Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Integrated Diagnostics to competition |
| Fundamentals | Integrated Diagnostics | Peer Average |
| Return On Equity | 0.23 | -0.31 |
| Return On Asset | 0.0969 | -0.14 |
| Profit Margin | 0.17 % | (1.27) % |
| Operating Margin | 0.16 % | (5.51) % |
| Current Valuation | 232.12 M | 16.62 B |
| Shares Outstanding | 581.33 M | 571.82 M |
| Shares Owned By Insiders | 33.97 % | 10.09 % |
| Shares Owned By Institutions | 42.29 % | 39.21 % |
| Price To Book | 4.15 X | 9.51 X |
| Price To Sales | 0.05 X | 11.42 X |
| Revenue | 4.12 B | 9.43 B |
| Gross Profit | 2.8 B | 27.38 B |
| EBITDA | 1.28 B | 3.9 B |
| Net Income | 737.36 M | 570.98 M |
| Total Debt | 1.18 B | 5.32 B |
| Book Value Per Share | 4.64 X | 1.93 K |
| Cash Flow From Operations | 543.66 M | 971.22 M |
| Earnings Per Share | 0.03 X | 3.12 X |
| Target Price | 27.67 | |
| Number Of Employees | 6.69 K | 18.84 K |
| Beta | 0.45 | -0.15 |
| Market Capitalization | 23.25 B | 19.03 B |
| Total Asset | 5.77 B | 29.47 B |
| Retained Earnings | 1.33 B | 9.33 B |
| Working Capital | 686.94 M | 1.48 B |
| Net Asset | 5.77 B |
Integrated Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Integrated . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 0.4 | |||
| Day Typical Price | 0.4 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.02 | |||
| Relative Strength Index | 40.85 |
About Integrated Diagnostics Buy or Sell Advice
When is the right time to buy or sell Integrated Diagnostics Holdings? Buying financial instruments such as Integrated Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Integrated Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gold and Gold Mining Thematic Idea Now
Gold and Gold Mining
Large and mid-size companies, ETFs and funds that are either investing, exploring or producing, gold or indirectly involved in trading or making gold products. The Gold and Gold Mining theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold and Gold Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.